Medical Research · MI
The Amyloidosis Foundation
The Amyloidosis Foundation reported paying Mary E Odonnell, President/ceo, $62,030 in total compensation (FY 2023).
That places Mary E Odonnell at approximately the 41st percentile among 149 similarly sized medical research nonprofits (median $73,133).
$535,162Total revenue (FY 2023)
$62,030Total executive compensation
41stPercentile vs. peers
Setting executive pay for this board?
Generate a board-ready comparability report for The Amyloidosis Foundation — named comparables, percentiles, methodology, and the 26 CFR 53.4958-6 minutes language a board can use toward the rebuttable presumption.
Build the comparability report →Comparable medical research nonprofits
Compensation is normalized to MI cost of living (BEA Regional Price Parities); each organization's reported figure is on its linked 990.
| Organization | State | Revenue | Total comp |
|---|---|---|---|
| Orthopaedic Innovation Technology | TN | $536,375 | $42,433 |
| Clinical Neurological Society Of | DC | $533,420 | $402 |
| Light Of Day Foundation Inc | NJ | $538,469 | $44,116 |
| Cdg Care | CO | $531,003 | $12,148 |
| Tarrant Eye Resources Inc | TX | $530,451 | $68,647 |
| Cured Nfp | IL | $540,978 | $5,715 |
| Sleep Research Society Foundation (Srsf) | IL | $528,992 | $9,251 |
| Heartland Cancer Foundation | NE | $527,925 | $70,442 |